021-51111890
购物车（）
sales@molnova.cn
Pomalidomide-PEG2-OH
CAS No. 2143097-10-1
Pomalidomide-PEG2-OH ( 1H-Isoindole-1,3(2H)-dione, 2-(2,6-dioxo-3-piperidinyl)-4-[[2-(2-hydroxyethoxy)ethyl]amino]- )
产品货号. M28648 CAS No. 2143097-10-1
Pomalidomide-PEG2-OH 能够合成用于靶向蛋白质降解的分子和 PROTAC（蛋白水解靶向嵌合体）技术。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ￥1159 | 有现货 |
|
| 10MG | ￥1720 | 有现货 |
|
| 25MG | ￥2678 | 有现货 |
|
| 50MG | ￥3636 | 有现货 |
|
| 100MG | ￥4725 | 有现货 |
|
| 200MG | ￥6210 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Pomalidomide-PEG2-OH
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述Pomalidomide-PEG2-OH 能够合成用于靶向蛋白质降解的分子和 PROTAC（蛋白水解靶向嵌合体）技术。
-
产品描述Pomalidomide-PEG2-OH enables the synthesis of molecules for targeted protein degradation and PROTAC (proteolysis-targeting chimeras) technology.
-
体外实验——
-
体内实验——
-
同义词1H-Isoindole-1,3(2H)-dione, 2-(2,6-dioxo-3-piperidinyl)-4-[[2-(2-hydroxyethoxy)ethyl]amino]-
-
通路Others
-
靶点Other Targets
-
受体CYP2C9|inflammation
-
研究领域——
-
适应症——
化学信息
-
CAS Number2143097-10-1
-
分子量361.35
-
分子式C17H19N3O6
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESOCCOCCNc1cccc(C(N2C(CCC(N3)=O)C3=O)=O)c1C2=O
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Takahashi H, et al. Pharmacokinetic interaction between warfarin and a uricosuric agent, bucolome: application of In vitro approaches to predicting In vivo reduction of (S)-warfarin clearance. Drug Metab Dispos. 1999 Oct;27(10):1179-86.
产品手册
关联产品
-
Crustacean Cardioact...
Crustacean cardioactive peptide (CCAP) is a highly conserved, amidated cyclic nonapeptide with the primary structure PFCNAFTGC-NH2 (ProPheCysAsnAlaPheTyrGlyCys-NH2) and a disulfide bridge between Cys3 and Cys9. It is found in crustaceans and insects where it behaves as a cardioaccelerator, neuropeptide transmitter for other areas of the nervous system and a hormone.
-
14-Deoxyandrographol...
14-Deoxyandrographolide 是穿心莲的一种生物活性化合物，具有保肝功效。它通过释放 TNFRSF1A 来降低肝细胞对 TNF-α 介导的细胞凋亡的敏感性。
-
Indecainide
Indecainide (Ricainid) is a novel antiarrhythmic compound that is carcinogenic and can be used to study chronic stable ventricular arrhythmias secondary to coronary artery disease or cardiomyopathy.
